The U.S. ambulatory surgery center market size was estimated at USD 40.41 billion in 2023 and is expected to grow at a CAGR of 6.02% from 2024 to 2030. The U.S. ambulatory surgery center devices market size was estimated at USD 26.57 billion in 2023 and is anticipated to grow at a CAGR of 8.89% from 2024 to 2030.The market growth can be attributed to rising investment in ambulatory surgery centers (ASCs) and favorable reimbursement for services at ASCs in the U.S. For instance, in January 2024, Tarrant Capital IP, LLC, an asset management firm, revealed a strategic investment in Compass Surgical Partners, an independent, full-service ASC management and development partner. The investment aims to accelerate Compass Surgical Partners’ growth, expand its capabilities, and enhance its ability to meet the rising demand for ASC joint ventures among healthcare system partners.
To learn more about this report, request a free sample copy
Ambulatory services have positively impacted the U.S. healthcare system, making care more accessible, efficient, and cost-effective for patients and providers. The number of inpatient admissions has significantly decreased in recent years due to shifting procedures to ASCs. In the U.S., more than 65% of surgeries are performed in ASCs. This is primarily due to high inpatient hospitalization costs and a rise in the adoption of advanced technologies by ASCs, enabling rapid & cost-effective treatment provision. Growing pressure from payers and Medicare has also increased the number of people preferring nearby ambulatory community care units for diagnostic tests over city hospitals.
Key U.S. Ambulatory Surgery Center Company Insights
The demand for ASCs has led to increased competition among companies in the market. Furthermore, increasing industry consolidation activities, such as partnership & collaboration, acquisitions, and mergers, by the top market players as well as growing initiatives in launching new products by key players are also anticipated to increase their share in the market.
Key U.S. Ambulatory Surgery Center Companies:
Service Providers:
Envision Healthcare Corporation (KKR & CO. Inc.) LLC
Tenet Healthcare Corporation
Mednax Services, Inc. (Pediatrix Medical Group, Inc.)
TeamHealth
UnitedHealth Group.
Quorum Health
Surgery Partners
Community Health Systems, Inc.
SurgCenter
Prospect Medical Systems
Edward-Elmhurst Health
Manufacturers
McKesson Corp.
BD.
Koninklijke Philips N.V.
3M
Olympus America
Abbott
Medtronic
Zimmer Biomet
Henry Schein, Inc.
STERIS Plc
Recent Developments
In January 2024, GE HealthCare announced the acquisition of MIM Software, a provider of medical imaging analysis and AI solutions for the practice of radiation molecular radiotherapy, oncology, urology, & diagnostic imaging at imaging centers, specialty clinics, hospitals, and research organizations worldwide
In December 2023, GE HealthCare introduced Vscan Air SL, a wireless ultrasound imaging system specifically developed for swift cardiac, portable, and vascular assessments at the point of care. The product was an addition to the company’s Vscan suite. The incorporation of XDclear and SignalMax technology can provide high-quality imaging performance with penetration, sensitivity, & resolution. Through this offering, the company aims to improve diagnosis rates and treatment decision efficiency
U.S. Ambulatory Surgery Center Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. ambulatory surgery center market report based on specialty, ownership, center type, device type, and region:
Specialty Outlook (Revenue, USD Billion, 2018–2030)
Orthopedics
Pain Management/Spinal Injections
Gastroenterology
Ophthalmology
Plastic Surgery
Otolaryngology
Obstetrics/Gynecology
Dental
Podiatry
Cardiology
Respiratory
Others
Ownership Outlook (Revenue, USD Billion, 2018–2030)
Physician Owned
Hospital Owned
Corporate Owned
Center Type Outlook (Revenue, USD Billion, 2018–2030)
Single-specialty
Multi-specialty
Device Type Outlook (Revenue, USD Billion, 2018–2030)
Orthopedic
Gastroenterology
Ophthalmology
Dermatology
Pain Management
Cardiology
Respiratory
Others
Regional Outlook (Revenue, USD Billion, 2018–2030)
Southeast
West
Midwest
Northeast
Southwest